FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

39013811000001107: Aybintio 100mg/4ml solution for infusion vials (Organon Pharma (UK) Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 28-Oct 2020. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1732901000001114 Aybintio 100mg/4ml solution for infusion vials (Organon Pharma (UK) Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1732921000001119 Aybintio 100mg/4ml solution for infusion vials (Organon Pharma (UK) Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Aybintio 100mg/4ml solution for infusion vials (Organon Pharma (UK) Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Aybintio 100mg/4ml solution for infusion vials (Organon Pharma (UK) Ltd) VMP prescribing status (attribute) Caution - AMP level prescribing advised true Inferred relationship Existential restriction modifier
Aybintio 100mg/4ml solution for infusion vials (Organon Pharma (UK) Ltd) Has excipient Polysorbate false Inferred relationship Existential restriction modifier
Aybintio 100mg/4ml solution for infusion vials (Organon Pharma (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction hospital only true Inferred relationship Existential restriction modifier
Aybintio 100mg/4ml solution for infusion vials (Organon Pharma (UK) Ltd) Is a Bevacizumab 100mg/4ml solution for infusion vials true Inferred relationship Existential restriction modifier
Aybintio 100mg/4ml solution for infusion vials (Organon Pharma (UK) Ltd) Has excipient Sorbic acid false Inferred relationship Existential restriction modifier
Aybintio 100mg/4ml solution for infusion vials (Organon Pharma (UK) Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Aybintio 100mg/4ml solution for infusion vials (Organon Pharma (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator EMA (European Medicines Agency) monitoring true Inferred relationship Existential restriction modifier
Aybintio 100mg/4ml solution for infusion vials (Organon Pharma (UK) Ltd) Is a Aybintio true Inferred relationship Existential restriction modifier
Aybintio 100mg/4ml solution for infusion vials (Organon Pharma (UK) Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Aybintio 100mg/4ml solution for infusion vials (Organon Pharma (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Aybintio 100mg/4ml solution for infusion vials (Organon Pharma (UK) Ltd) Has specific active ingredient Bevacizumab true Inferred relationship Existential restriction modifier
Aybintio 100mg/4ml solution for infusion vials (Organon Pharma (UK) Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product false Inferred relationship Existential restriction modifier
Aybintio 100mg/4ml solution for infusion vials (Organon Pharma (UK) Ltd) Has dispensed dose form Conventional release solution for infusion true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Aybintio 100mg/4ml solution for infusion vials (Organon Pharma (UK) Ltd) 1 vial Has AMP True Aybintio 100mg/4ml solution for infusion vials (Organon Pharma (UK) Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start